About ChemRegen
ChemRegen is a company based in San Diego (United States) founded in 2009.. ChemRegen offers products and services including PAWI-2, Cardiac Regeneration Technology, Breast Cancer Research, and Colorectal Cancer Therapy. ChemRegen operates in a competitive market with competitors including Tenaya Therapeutics, Orca Bio, Athira Pharma, Histogenics and Organogenesis, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chemregen, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$240.56 K (USD), Grant
Jun 01, 2014
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ChemRegen
ChemRegen offers a comprehensive portfolio of products and services, including PAWI-2, Cardiac Regeneration Technology, Breast Cancer Research, and Colorectal Cancer Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug that inhibits pancreatic cancer stem cells and synergizes standard treatments.
Technology for developing treatments using stem cells for cardiac repair.
Research focused on regenerative approaches for breast cancer treatment.
Development of drugs targeting colorectal cancer through stem cell methods.
Unlock access to complete
Unlock access to complete
Funding Insights of ChemRegen
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $240,555
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2014 | Amount | Grant - ChemRegen | Valuation |
investors |
|
| Jul, 2011 | Amount | Grant - ChemRegen | Valuation |
investors |
|
| Mar, 2011 | Amount | Grant - ChemRegen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ChemRegen
ChemRegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Heart, Lung, and Blood Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Research on heart, lung, blood, and sleep disorders is conducted.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ChemRegen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ChemRegen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chemregen Comparisons
Competitors of ChemRegen
ChemRegen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Orca Bio, Athira Pharma, Histogenics and Organogenesis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
|
| domain | founded_year | HQ Location |
Restorative cell therapies for orthopedic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Engineered cell and gene therapies are developed for multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chemregen
Frequently Asked Questions about ChemRegen
When was ChemRegen founded?
ChemRegen was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is ChemRegen located?
ChemRegen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
What does ChemRegen do?
ChemRegen is focussed on developing regenerative medicine for a range of diseases. Based on the stem cell biology, it has discovered small molecule regenerative medicine candidates which work in conjunction with the embryonic stem cells for the development of functionally active drugs. It currently has 2 major small molecule programs for heart disease and cancer. In partnership with the Human BioMolecular Research Institute Sanford-Burnham Medical Research Institute, it has developed a small molecule along ITD-1 which can be used to new heart cells from stem cells.
Who are the top competitors of ChemRegen?
ChemRegen's top competitors include Tenaya Therapeutics, Athira Pharma and Orca Bio.
What products or services does ChemRegen offer?
ChemRegen offers PAWI-2, Cardiac Regeneration Technology, Breast Cancer Research, and Colorectal Cancer Therapy.
Who are ChemRegen's investors?
ChemRegen has 2 investors. Key investors include HHS, and National Heart, Lung, and Blood Institute.